What happens if I have urgent medical questions
& Wilding, J
Stopping GLP-1 therapy in diabetic patients risks not only weight regain but also deterioration of blood sugar control, potentially requiring additional diabetes medications
Unequivocally, we do not see the same effects in humans as we do in rodents, says Elizabeth Pearce, MD, an endocrinologist and thyroid specialist at Boston Medical Center
21 Liraglutide showed no effect on the hierarchical primary endpoint of time to death, time to rehospitalisation for HF and time-averaged change in N-terminal pro B-type natriuretic peptide (NT-proBNP) from baseline to 180 days (p=0.31), with even an increased risk of emergency department visit, HF hospitalisation or all-cause death events (HR 1.36
If your appetite is poorly controlled and weight loss has stalled, staying at a lower dose will not improve the situation